These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6676898

  • 21. [Amikacin and tobramycin].
    Bergan T, Melby K.
    Tidsskr Nor Laegeforen; 1978 Apr 30; 98(12):639-41. PubMed ID: 653664
    [No Abstract] [Full Text] [Related]

  • 22. [Comparative evaluation of the activity "in vitro" of 4 aminoglycosides (gentamycin, sisomicin, tobramycin, amikacin)].
    Pinto L, Nobili B, Marchi K, Di Lena C, Esposito L.
    Pediatria (Napoli); 1979 Sep 30; 87(3):399-406. PubMed ID: 550114
    [No Abstract] [Full Text] [Related]

  • 23. Comparative ototoxicity of BB-K8 (amikacin), gentamicin, sisomicin and tobramycin in the guinea pig.
    Brummett RE, Fox KE.
    Proc West Pharmacol Soc; 1977 Sep 30; 20():449-53. PubMed ID: 896854
    [No Abstract] [Full Text] [Related]

  • 24. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    Yu VL, Rhame FS, Pesanti EL, Axline SG.
    JAMA; 1977 Aug 29; 238(9):943-7. PubMed ID: 328950
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The nephrotoxicity and renal accumulation of amikacin, tobramycin and gentamycin in rats, rabbits and guinea pigs.
    Sairio E, Kasanen A, Kangas L, Nieminen AL, Nieminen L.
    Exp Pathol (Jena); 1978 Aug 29; 15(6):370-5. PubMed ID: 744211
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
    Alegente G, Marchi B, Pieri I, Saturni A, Progenie G, Rubino M.
    Quad Sclavo Diagn; 1983 Sep 29; 19(3):343-8. PubMed ID: 6677931
    [Abstract] [Full Text] [Related]

  • 30. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé.
    Med Mal Infect; 2012 Jul 29; 42(7):301-8. PubMed ID: 22770656
    [No Abstract] [Full Text] [Related]

  • 31. Determinants of resistance to various aminoglycoside antibiotics.
    Pisano A, Mattina R, Nicoletti G.
    Antibiotica; 1977 Mar 29; 14(1):58-72. PubMed ID: 879719
    [No Abstract] [Full Text] [Related]

  • 32. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I, Voeckl J, Machka K.
    Arzneimittelforschung; 1980 Mar 29; 30(3):491-5. PubMed ID: 7387761
    [Abstract] [Full Text] [Related]

  • 33. [Amikacin in the treatment of Gram negative bacilli septicemias].
    Cartier F, Dien G, Cormier M, Hoel JC, Guivarch G.
    Nouv Presse Med; 1979 Oct 31; 8(42):3510-12. PubMed ID: 537908
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of the ototoxicity of aminoglycosides. Comparison of tobramycin and gentamycin. Preliminary report].
    Fee WE.
    Nouv Presse Med; 1978 Nov 29; 7(42):3854-5. PubMed ID: 309592
    [No Abstract] [Full Text] [Related]

  • 35. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J, Thomas M, Shanmugam J.
    Indian J Pathol Microbiol; 1985 Apr 29; 28(2):115-9. PubMed ID: 3835114
    [No Abstract] [Full Text] [Related]

  • 36. [Control of the resistance of gram-negative bacilli to aminoglucosides. Results of a 3-year prospective study with the exclusive use of amikacin].
    Ruiz-Palacios G, Ponce de León S, Sifuentes J, Ponce de León S, Calva J, Huazano F, Ontiveros C, Ojeda F, Bobadilla M.
    Rev Invest Clin; 1986 Apr 29; 38(1):1-6. PubMed ID: 3738260
    [No Abstract] [Full Text] [Related]

  • 37. Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
    Levy J, Baran D, Klastersky J.
    J Antimicrob Chemother; 1982 Sep 29; 10(3):227-34. PubMed ID: 6815155
    [No Abstract] [Full Text] [Related]

  • 38. Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration.
    Woo FL, Johnson AP, Insler MS, George WJ, LaCorte WS.
    Arch Ophthalmol; 1985 Feb 29; 103(2):216-8. PubMed ID: 3977692
    [Abstract] [Full Text] [Related]

  • 39. Amikacin.
    Lancet; 1975 Oct 25; 2(7939):804-5. PubMed ID: 78162
    [No Abstract] [Full Text] [Related]

  • 40. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M, Brun Y, Forey F, Fleurette J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3391-5. PubMed ID: 7155846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.